Mirati Therapeutics, Inc.

VANGUARD GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

3/11/2024

Shares

5,306,693

Value ($000)

311,768

Weight

0.0%

2013 Q4 - 2023 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	3/11/2024	311,768	0.0%	5,306,693	12/31/2023
2023 Q3	12/18/2023	248,276	0.0%	5,699,632	9/30/2023
2023 Q2	8/14/2023	179,865	0.0%	4,978,275	6/30/2023
2023 Q1	7/14/2023	187,736	0.0%	5,049,375	3/31/2023
2022 Q4	2/10/2023	225,367	0.0%	4,973,888	12/31/2022
2022 Q3	11/14/2022	330,225	0.0%	4,728,299	9/30/2022
2022 Q2	8/12/2022	305,308	0.0%	4,548,021	6/30/2022
2022 Q1	5/13/2022	368,577	0.0%	4,482,810	3/31/2022
2021 Q4	2/14/2022	651,154	0.0%	4,438,977	12/31/2021
2021 Q3	11/12/2021	732,028	0.0%	4,137,857	9/30/2021
2021 Q2	8/13/2021	667,834	0.0%	4,134,423	6/30/2021
2021 Q1	5/14/2021	717,265	0.0%	4,187,185	3/31/2021
2020 Q4	2/12/2021	885,640	0.0%	4,032,238	12/31/2020
2020 Q3	11/16/2020	555,290	0.0%	3,344,122	9/30/2020
2020 Q2	8/14/2020	393,796	0.0%	3,449,202	6/30/2020
2020 Q1	5/15/2020	261,621	0.0%	3,403,438	3/31/2020
2019 Q4	2/14/2020	395,293	0.0%	3,067,611	12/31/2019
2014 Q2	8/11/2014	4,202	0.0%	210,098	6/30/2014
2014 Q1	5/13/2014	3,685	0.0%	193,250	3/31/2014
2013 Q4	2/12/2014	2,980	0.0%	179,181	12/31/2013